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Abstract:   Fullerenic  soluble  derivatives are essential for many 
biomedical techniques that exploit the chemical and physical properties of 
these unique structural carbon nanospheres. Their toxicity, demonstrated in 
vitro and in vivo is important for the characterization and the limitation of 
these applications. The photo toxicity of some fullerene molecules has been 
identified as a future therapeutic tool. The specific objective of the study is 
the synthesis of C60 derivatives. Starting from the characteristics of 
fullerene compounds, we tried to study in vitro C60 fullerene and some 
functionalized derivatives (C60 complexes with poly-vinyl pyrrolidone 
(PVP) and with the oxo-dimer (Fe-O)2TPP), experimental models in vitro 
with normal and tumor cells and investigation of their toxicological profile, 
in order to identify novel anti-neoplasic therapeutic devices. 
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INTRODUCTION 
 
Starting from the characteristics of fullerene compounds, we tried to study in vitro C60 
fullerene and some functionalized derivatives (C60 complexes with PVP (poly-vinyl 
pyrrolidone) and with the oxo-dimer (Fe-O)2TPP), experimental models in vitro with 
normal and tumor cells and investigation of their toxicological profile, in order to 
identify novel anti-neoplasic therapeutic devices.  
The compounds were characterized using UV-VIS and IR spectroscopy as well as 
considering their biomedical applications. 
 
 
EXPERIMENTAL 
 
Materials 
 
Free-base tetraphenylporphyrin (TPP) was synthesized in our lab, after own proper 
method [1 – 3]. UV-Vis (nm, log ε) in benzonitrile: 415(5.45), 511.5(4.15), 544 (3.82), 
589(3.71), 642(3.59). 
TPP-PVP-C60 complex have been synthesized in liquid phase by evaporation of a 
combined solution TPP (99.9%)/PVP and C60 (99.95%) and in toluene : chloroform = 
1:1 with a molar ratio 1:6 at 150 °C, as previously reported [3]. 
For the synthesis of TPPFeCl we have used 0.0270 g FeCl3 (in 50 mL glacial acetic 
acid), 1 mL benzaldehyde and 0.7 mL pyrol. After the synthesis it was obtained a black-
purple precipitate.  
Oxo-iron-porphyrin dimmer was obtained as following: after dissolving 0.5 g in 60 mL 
CHCl3 TPPFeCl (reflux one hour) were added to 50 mL 25% KOH. The complex 
(TPP-Fe)2-O was separated by column chromatography on alumina and eluted with 
chloroform. 
 
Apparatus 
 
A M400 Carl Zeiss Jena UV spectrophotometer with a 1 nm slit width, 1 nm step size, 
0.3 nm.s
-1 average scan rate, deuterium lamp, and quartz cell was used to measure the 
aqueous solution absorbance and the molar absorption spectra for each sample. The 
spectrophotometer has been connected to an external computer for data processing. 
The FT-IR spectra were recorded on a FT-IR GX Perkin Elmer, working domain 4000 - 
400 cm
-1, Dynascan interferometer, DTGS detector, equipped with ATR (Attenuated 
Total Reflectance) device. 
 
Cells 
 
K562 lymphoblastic human cell line (supplier ATCC Nr. CCL-243) derived from 
chronic leukemia [4] was used. Cells were maintained in culture or cryopreserved as 
stated by the supplier. In all the PDT experimental systems the cell line was used in 
RPMI1640 complete medium without phenol red in order to avoid the interference with 
the detection methods.  BIOMEDICAL MATERIALS BASED ON FULLERENES  
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Biological tests 
 
The loading was performed at various incubation time, cell concentration and photo 
sensitizer concentration. The following experimental conditions have been established: 
incubation time 1 – 48 h, the photosensitizers loaded in the 5 – 250 µg.mL
-1 range and 
the cell suspension in the (0.05÷1.5)×10
6 cells.mL
-1 concentration range. The loading 
degree was indirectly measured by spectra registration of cellular supernatants by means 
of recording absorption spectra for each of them (supernatant and lysate). 
 
Irradiation 
 
Cell suspensions, pre-incubated for 24 h with TPP-C60-PVP, were subjected to 
irradiation after washing them 3 times in culture medium and resuspended at 2×10
5 
cells.mL
-1 in RPMI1640 culture medium without phenol red or FCS (fetal calf serum). 
The cell suspensions irradiation was performed with a 450-W Hanovia medium pressure 
Hg lamp in quartz well equipped with an UV39 filter (436 nm filter). Samples were 
placed in a quartz cuvette. Exposure times necessary to achieve UV fluences from 0 to 
1000 mJ.cm
-2 at fluence rates of 20, 100 or 200 mW.cm
-2, were determined from the 
average irradiance as calculated with a spreadsheet program using the lamp spectrum, 
solution absorbance, the incident irradiance read from a calibrated radiometer (IL1700, 
SED 240/W, International Light, Peabody, MA). Light flux was measured in terms of 
irradiation at wavelengths which correspond to absorbance bands of the sensitizer.   
After irradiation, the cells were washed again twice in RPMI1640 culture medium 
without phenol red with FCS for removal of cell debris generated during irradiation.  
 
Cell viability  
 
Cell membrane integrity was assessed using Cytotox96 Non-Radioactive Cytotoxicity 
Assay kit (Promega Corporation) [5], a test that quantifies lactate dehydrogenase (LDH) 
release by damaged cells. LDH release was presented as LDH index = OD 490 nm of 
cells in presence of compound/OD 490 nm of control cells. Trypan Blue exclusion test 
was performed in order to establish the percentage of dead cells. Cell viability results 
were expressed as index (viability index = cell viability in presence of compound/cell 
viability of control).  
 
Cell proliferation  
 
The capacity of tumoral cell line to proliferate was assessed as number of metabolically 
active cells, using the CellTiter 96AQueous One Solution Cell Proliferation kit 
(Promega Corporation) [6]. The test measures the activity of intracellular 
dehydrogenases based on tetrazolium salt reduction to a spectrophotometrically 
quantifiable soluble formazan compound. Results are expressed as index (MTS index = 
OD 490 nm of cells in presence of compounds/OD 490 nm of control cells).  
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RESULTS AND DISCUSSION 
 
The electronic absorption spectrum of TPP is dominated by the very strong Soret band 
located at 428 nm. The symmetrical Soret band suggests an absence of molecular 
aggregates observed. Also, in the absorption spectrum of TPP, could be observed in the 
region 500 – 700. By coupling TPP with PVP and C60, the very narrow and 
symmetrical Soret absorption band in absorption spectrum is bathochromically shifted 
to 437 nm, suggesting an electronic interaction between the porphyrin and fullerene 
moieties. The Q bands (from 500 to 700 nm) in this triad also undergoes medium 
bathochromic shift by about 9 nm [3]. All these experiments have been achieved in 
CHCl3 : toluene (1:1) (Figure 1).  
Because in DMSO : water (the solvent used for biological tests in the following ratio: 
0.05% - 99.95%), TPP exists in dicationic form, it can interact electrostatically (with the 
positive charged nitrogen of the pyrrolidone ring) with the negative oxygen atom 
(lactam carbonyl group) from PVP. Taking into account all these data, we presume that 
the possible structure of the TPP-PVP-C60 triad is the one presented in Figure 2.  
 
 
Figure 1. UV-Vis spectra of C60(……), TPP(____) and TPP-C60-PVP (-----) 
 
 
Figure 2. The structure of TPP/PVP/C60 [3] 
 
In Figure 3 is presented the FT-IR spectra of the triad, as well as those of the precursors. 
The proposed structure and the UV-Vis characterization for the complex C60-(TPP-
Fe)2-O are presented in Figures 4 and 5.  BIOMEDICAL MATERIALS BASED ON FULLERENES  
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Figure 3. FT-IR spectra of PVP (green), C60 (red), TPP (blue) and triad (black)[3] 
 
 
Figure 4. The proposed structure of  C60-(TPP-Fe)2O 
 
Considering that the long range purpose of the study is the biomedical application of the 
compound, the in vitro cytotoxicity profile is obviously an important start point. In the 
0.05 – 50 μM TPP-C60 concentration range, the LDH release from metabolically active 
K562 cells incubated for 1-6-18 h displayed the same pattern (Figure 6). We have 
obtained at higher than 5 μM an increase of the LDH release compared to controls while 
concentrations above 25 μM kill over 50% of the cells. For studying the loading 
efficiency we have detailed the lower than 5 μM concentration namely 0.25 – 1 μM 
range, using 1 – 18 h incubation time. 
Cells were efficiently loaded with the 0.5 μM concentration, thus for irradiation we 
have chosen the mentioned concentration. 
The actual cell counting showed that after irradiation we recover a mean of 20% when 
cells were loaded for 18 h compared to an 80% in unloaded and irradiated controls 
(Figure 7) [3]. FIERASCU, DUMITRIU, ION, BUNGHEZ, NEAGU, CONSTANTIN and STAVARU 
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Figure 5. UV-Vis spectra of C60,(TPP-Fe)2-O and C60-(TPP-Fe)2-O 
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Figure 6. LDH release from metabolically active K562 cell line (MTS) in presence 
TPP-C60 in non-irradiated protocols represented as OD 450 nm (mean ± SD of 6 
individual experiments with triplicates/sample) [3] 
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Figure 7. Cellular number decrease in K562 cells loaded with 0.5 μM TPP-C60 after 
1 and 18 h of incubation subjected to irradiation represented as index = cell number 
sample/cell number control (mean ± SD of 5 individual experiments with 
triplicates/sample) BIOMEDICAL MATERIALS BASED ON FULLERENES  
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LDH has a high specific activity among glycolytic enzymes in tumor cell lines, whereas 
proliferating or growth arrested and it is co-localized with other components in the 
mitochondria [7]. We have used LDH testing not only as a marker for cellular 
membrane damage upon irradiation but as well as an indicator for mitochondrion 
integrity. We have obtained that, while cells after 1 h incubation in 0.5 μM subjected to 
irradiation have statistically the same LDH release and intracellular content (Figure 8) 
after a longer incubation cells display a clear increase in the LDH release while the pool 
of intracellular LDH diminishes. 
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Figure 8. LDH content and LDH release from K562 cells loaded with 0.5 μM and 
subjected to irradiation represented as index = OD 490 nm sample/OD 490 nm 
control (mean ± SD of 5 individual experiments with triplicates/sample) 
 
In Figure 9 are presented the viability and proliferation capacity of tumor line (K562) 
traced at different intervals in the presence of C60-(TPP-Fe)2-O. Values are expressed 
as OD×1000.  
 
 
Figure 9. Viability and proliferation capacity of C60, C60-(TPP-Fe)2-O and control 
on K562 cell line 
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CONCLUSIONS 
 
New materials based on fullerenes (C60-(TPP-Fe)2-O, C60-PVP-TPP) have been 
synthesized, analytically characterized and their biomedical effects studied. 
The results are promising, allowing the use of compounds synthesized in the 
photodynamic therapy of cancer.  
The presented dyad compound complexed with polyvinylpyrolidone displays on a wide 
range of concentration “dark” non-toxicity profile. We have shown induces apoptosis 
but not caspase-3 mediated. Due to its anti-tumoral activity, the TPP-C60 can be further 
developed as a more efficient drug delivery system  in photodynamic therapy 
approaches. 
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